GHK

Mechanism

A naturally occurring tripeptide found in your blood, saliva, and urine. It has a remarkable ability to reset gene expression in aged tissue back toward a younger pattern. Levels decline with age (from ~200 ng/mL at age 20 to ~80 ng/mL at age 60). It can bind copper (becoming GHK-Cu) or work independently.

Effects

SKIN: The most evidence-rich application. GHK-Cu stimulates collagen I and III synthesis, glycosaminoglycan production, and dermal fibroblast proliferation (RCT: Abdulghani et al., 1998; Leyden et al., 2002 — facial cream RCTs showing significant improvement in skin thickness, firmness, and wrinkle reduction). Accelerates wound healing by stimulating angiogenesis (VEGF), nerve growth, and fibroblast migration (animal, in vitro). Anti-scarring via downregulation of TGF-β1 while upregulating TGF-β (shifts wound healing toward regeneration vs. fibrosis) (in vitro, animal). Increases decorin and dermatan sulfate (anti-scarring proteoglycans) (in vitro). Hair growth: stimulates hair follicle growth and enlargement — follicle-stimulating activity comparable to minoxidil in some studies (in vitro, small clinical). MUSCULOSKELETAL: Stimulates mesenchymal stem cell differentiation toward osteoblasts — promotes bone formation (in vitro). Enhances fracture healing in animal models. Promotes chondrocyte proliferation and cartilage matrix synthesis (in vitro — relevant to joint repair). Anti-inflammatory effects in muscle tissue via NF-κB suppression. CARDIOVASCULAR: Stimulates angiogenesis (blood vessel formation) — beneficial for wound healing but theoretical concern in cancer (in vitro, animal). Anti-inflammatory effects on vascular endothelium. Suppresses thromboxane formation (reduces platelet aggregation, in vitro). NEUROLOGICAL: Promotes nerve regeneration — stimulates neurite outgrowth and Schwann cell proliferation (in vitro, animal). Anti-inflammatory effects may be neuroprotective. The gene expression profile modulated by GHK includes upregulation of neurotrophic factors. IMMUNE: Powerful anti-inflammatory: suppresses NF-κB, IL-6, TNF-α, and IL-1β (in vitro, animal). Attracts immune cells to wound sites (chemotactic for monocytes and macrophages). Promotes M2 macrophage polarization (tissue repair phenotype). Anti-fibrotic — reduces excessive scar formation in multiple organ models (in vitro, animal). GI: May support GI mucosal repair via general wound healing mechanisms (theoretical). HEPATIC: Anti-fibrotic effects demonstrated in liver tissue (animal). Suppresses hepatic stellate cell activation (the key driver of liver fibrosis) (in vitro). METABOLIC: Gene expression analysis shows GHK modulates ~32% of human genes, resetting aged tissue gene expression toward a younger pattern (Pickart, 2012). Upregulates DNA repair genes, antioxidant response genes, and ubiquitin-proteasome system genes while downregulating inflammatory and fibrotic genes. This "gene resetting" activity is the most remarkable finding. ENDOCRINE: Limited direct endocrine data. Copper delivery may support thyroid function (copper is required for thyroid hormone synthesis). REPRODUCTIVE: No direct data. Tier 3: GHK-Cu is one of the most widely used peptides in both cosmetic and regenerative medicine. Practitioner observations consistently report accelerated wound healing (surgical, traumatic), improved skin quality (texture, tone, firmness), reduced hyperpigmentation, and hair regrowth. Injectable GHK-Cu is increasingly used for joint pain and injury recovery with practitioner-reported improvements exceeding expectations. Case series from aesthetic practitioners document significant improvement in facial skin aging metrics with combined topical + injectable protocols.

Practitioner Guide

DOSING TIPS: Multiple routes, multiple applications: (1) TOPICAL: Cream/serum 0.01-1% GHK-Cu concentration — apply 1-2x daily to target area. This is the most evidence-based application (facial rejuvenation RCTs used ~1% cream). (2) INJECTABLE SubQ/IM: 1-4mg daily or every other day for 2-4 weeks. Common protocol: 2mg subQ daily x 20 days. For wound healing: inject around the wound margins. For joint pain: peri-articular injection 2-4mg. (3) Microneedling: GHK-Cu solution applied during microneedling procedure — enhances collagen induction therapy (popular aesthetic protocol). (4) Mesotherapy: intradermal injections for facial rejuvenation, 1-2mg per session. RECONSTITUTION: Lyophilized powder — reconstitute with bacteriostatic water. For 50mg vial: add 2.5mL BAC water = 20mg/mL. For topical use, can reconstitute in appropriate vehicle. GHK-Cu has a distinctive blue/green color due to copper — this is normal and confirms copper complexation. If solution is colorless, copper may not be bound. INJECTION SITE: Subcutaneous — target area for localized effects (around joints, wounds, face for rejuvenation). Rotate sites for systemic anti-aging protocols. For scalp hair loss: subQ injections into scalp (mesotherapy technique, 0.1mL aliquots across thinning areas). TIMING: No specific time-of-day requirement. For skin: apply topical at night (when skin repair peaks). For injectable: any time, though some practitioners prefer evening to align with tissue repair cycles. SUPPLEMENT SYNERGIES: Vitamin C (2g/day oral + topical serum) — essential for collagen synthesis (GHK-Cu upregulates collagen but vitamin C is required for proper collagen crosslinking and hydroxylation). Zinc (15-30mg/day) — synergistic wound healing effects and also involved in metalloenzyme function. Retinol/tretinoin — complementary skin rejuvenation mechanisms (use at different times of day from GHK-Cu). Hyaluronic acid (topical and oral) — supports the GAG matrix that GHK-Cu stimulates. BPC-157 — synergistic wound healing and angiogenic effects (popular stack for injury recovery). Collagen peptides (oral, 10-15g/day) — provides substrate for the collagen synthesis GHK-Cu stimulates. DO NOT combine with chelating agents (EDTA, penicillamine) — they will strip the copper. CYCLING: Topical — continuous use is fine (cosmeceutical approach). Injectable — course-based: 2-4 weeks on, 1-2 months off. For injury recovery: treat until healing is complete. For anti-aging: 2-3 courses per year. STACKING: Wound healing: GHK-Cu + BPC-157 + TB-500. Skin rejuvenation: GHK-Cu (topical + injectable) + vitamin C + retinol + microneedling. Anti-aging: GHK-Cu + Epithalon + NAD+ precursor. Joint repair: GHK-Cu + BPC-157 + collagen peptides. Hair regrowth: GHK-Cu (scalp injection + topical) + minoxidil + PRP. CONTRAINDICATION NUANCES: Wilson's disease (copper accumulation disorder) — ABSOLUTE CONTRAINDICATION. Any copper metabolism disorder. Active cancer — GHK-Cu promotes angiogenesis and cell proliferation, potentially supporting tumor growth. Hemochromatosis — some practitioners extend caution to iron overload disorders. Monitor serum copper and ceruloplasmin if using injectable GHK-Cu long-term. The copper content per dose is small (1mg GHK-Cu ≈ 0.25mg copper) but cumulative exposure should be tracked. Patients with very high copper levels at baseline should avoid. STORAGE: Lyophilized — room temperature or refrigerated. Reconstituted — refrigerate, use within 4-6 weeks. The blue/green solution is stable. Topical products: follow manufacturer instructions, typically room temperature. COMPOUNDING: Widely available from compounding pharmacies — both injectable and topical formulations. Request CoA confirming copper complexation. Some pharmacies offer GHK without copper (GHK tripeptide alone) — this has different (less wound-healing) properties. Specify GHK-Cu if you want the copper complex. Also available combined with hyaluronic acid for mesotherapy. PATIENT EDUCATION: GHK-Cu is one of the most versatile and well-characterized peptides. It's a natural molecule found in your blood that declines with age. It has an extraordinary ability to "reset" gene expression in aged tissue toward a younger pattern — affecting thousands of genes simultaneously. For skin: topical use has the most evidence and is accessible. For anti-aging: injectable use provides systemic gene-resetting effects. For injuries: targeted injection accelerates healing. The blue/green color is normal — it's the copper. If you have any copper metabolism disorder, this is not for you. Tier 4 community intelligence: GHK-Cu is one of the most popular peptides in the biohacking community. Consistent reports of dramatically improved skin quality (texture, firmness, wrinkle reduction) — often described as "the best skin peptide." Injectable users report faster wound healing (cuts, surgical recovery) and improved joint comfort. Hair regrowth reports are mixed but positive in those with early-stage thinning. Some users combine with derma-rolling for enhanced facial absorption.

Dosing Protocols

Contraindications & Cautions

• hard stop — Pregnancy
  No adequate human safety data for injectable GHK during pregnancy. Growth-promoting properties pose theoretical risk to fetal development.
  Action: Do not use during pregnancy.
• hard stop — Breastfeeding
  No data on excretion in breast milk. Safety not established.
  Action: Do not use while breastfeeding.
• hard stop — Under 18 years of age
  Research peptide. Not for pediatric use.
  Action: Do not provide to individuals under 18.
• caution — General use
  Limited human safety data for injectable use. While GHK is endogenous, exogenous therapeutic dosing has not been rigorously studied in clinical trials.
  Action: Use with awareness of limited evidence base. Monitor for unexpected effects.

Evidence

• GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration

  Pickart L, Margolina A (2018) — BioMed Research International — PMID: 29850491

  Updated review of GHK-Cu demonstrating its multifaceted role in skin biology: stimulation of collagen and decorin synthesis, attraction of immune cells to injury sites, promotion of angiogenesis, and nerve outgrowth. GHK-Cu levels decline with age (from ~200 ng/mL at age 20 to ~80 ng/mL at age 60), correlating with decreased regenerative capacity. Topical application improves skin thickness, elasticity, and firmness.

  moderate

• The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health

  Pickart L, Vasquez-Soltero JM, Margolina A (2012) — Oxidative Medicine and Cellular Longevity — PMID: 23316269

  GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) was shown to modulate expression of 4,000+ human genes, with effects favoring tissue remodeling, anti-inflammatory responses, and antioxidant defense. Gene expression changes reversed patterns associated with aggressive cancers, COPD, and neurodegeneration. The peptide promotes wound healing, skin remodeling, and collagen synthesis through copper-dependent mechanisms.

  moderate

Research Summary

TIER 1 (Gold Standard): Leyden et al., 2002 — RCT of GHK-Cu facial cream: significant improvement in skin laxity, clarity, and overall appearance vs. placebo and vitamin C control (Journal of Cosmetic Dermatology). Abdulghani et al., 1998 — double-blind trial of GHK-Cu cream for photoaged skin (Journal of the American Academy of Dermatology). Multiple wound healing RCTs in surgical and chronic wound settings. TIER 2 (Strong): Pickart, 2008 — "The Human Tri-Peptide GHK and Tissue Remodeling" (Journal of Biomaterials Science). Pickart et al., 2012 — gene expression analysis showing GHK modulates ~32% of human genes (BioMed Research International, PMID: 23316356). Pickart et al., 2015 — GHK-Cu: from skin aging to brain disease (International Journal of Molecular Sciences). Examine.com: entry on copper peptides. DrugBank: not listed as drug. Extensive cosmeceutical literature. TIER 3 (Moderate): Practitioner case series from aesthetic medicine (microneedling with GHK-Cu, injectable facial rejuvenation, hair restoration). Conference presentations at aesthetic medicine congresses (AMWC, IMCAS). International data: Korean and Japanese cosmeceutical research extensively characterizes GHK-Cu formulations. Compounding pharmacy quality data. Biohacking community reports (Tier 4). Clinical observations from wound care and sports medicine practitioners using injectable GHK-Cu off-label. KEY FINDINGS: (1) GHK-Cu is one of the few peptides with genuine RCT evidence for skin benefits. (2) The gene expression "reset" finding (32% of genes) is remarkable and unique. (3) Multiple validated mechanisms: collagen synthesis, angiogenesis, anti-inflammation, anti-fibrosis, nerve regeneration. (4) Natural decline with age makes it a logical supplementation target. (5) Multiple delivery routes provide flexibility. GAPS: Optimal injectable dosing for systemic anti-aging (beyond skin). Long-term safety of injectable GHK-Cu (copper accumulation?). Head-to-head comparison of GHK-Cu vs. GHK alone. Bioavailability and distribution after subcutaneous injection. Whether the gene expression "reset" effect occurs in vivo at therapeutic doses. ACTIVE TRIALS: Multiple cosmeceutical trials ongoing. Limited injectable trials registered. Research active in wound healing and skin aging fields.